Viewing nowBoniam 150mg (Ibandronate Sodium Monohydrate)
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 201205573 · Approved 2012.06.15 · Insurance code 648506730
Improvement of postmenopausal osteoporosis
This medication is used to treat osteoporosis, which is common in postmenopausal women. Osteoporosis is a condition where the strength of the bones weakens and the risk of fractures increases. This drug strengthens bones and increases bone density to reduce the risk of fractures. With consistent use, it helps improve bone health. It is effective for the treatment of osteoporosis in postmenopausal women.
Take 1 tablet once a month regularly on the same day in the morning at least 1 hour before consuming any food, beverages (except water), or other orally taken medications or dietary supplements (including calcium). - This drug should be swallowed with a sufficient amount (180-240 mL) of water while standing or sitting upright, and do not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medication.
Safety and efficacy in children under 18 years have not been studied.
This medication should not be used in certain patients. For instance, patients who are allergic to this drug or its components, patients with untreated hypocalcemia, patients who cannot remain upright for more than 60 minutes, patients with esophageal problems that slow the passage of food, and patients with genetic issues like lactose intolerance should not be treated with this drug. Care should be taken when administering this drug to patients with severe renal impairment. This medication may cause gastrointestinal irritation, leading to symptoms such as dyspepsia, nausea, abdominal pain, and diarrhea. In addition, adverse reactions such as headache, myalgia, arthralgia, and rash have been reported. In some patients, flu-like symptoms such as fever, chills, and fatigue may occur temporarily. If symptoms such as esophagitis, esophageal ulcer, dysphagia, pain behind the sternum, or heartburn occur during usage, the medication should be discontinued immediately, and a doctor should be consulted. When used in combination with nonsteroidal anti-inflammatory drugs, gastrointestinal irritation may increase, hence caution is needed. A serious side effect called osteonecrosis of the jaw may occur rarely, so if dental treatment is needed, a dental examination should be done in advance and a treatment plan established. Moreover, this medication may increase the risk of atypical fractures in specific areas, so if there is pain in the thigh or groin, an immediate evaluation by a physician is necessary. This drug may have its absorption hindered if taken with food, milk, calcium supplements, or antacids, so do not consume any other food or drugs for at least 1 hour after taking it. Women who are pregnant or breastfeeding should avoid the use of this medication. Safety and efficacy in children and adolescents under 18 years have not been established. In case of overdose, gastrointestinal disturbances or hypocalcemia may occur, and do not induce vomiting; the patient should remain upright. Keep this drug out of the reach of children, and the unused medication should be disposed of properly to prevent environmental contamination.
Hives, severe swelling (angioedema, facial swelling), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, mucosal pain in the mouth/eyes, wheezing or difficulty breathing, asthma attacks, respiratory distress associated with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at a cool room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer period.
White to almost white oblong film-coated tablet
1 tablet (1 tablet/PTP x 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.